Brief: NATCO Pharma Says NATCO Pharma Asia Buys 49% Of PT Natco Lotus Farma
30/01/2026 07:17
Jan 30 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA - NATCO PHARMA ASIA BUYS 49% OF PT NATCO LOTUS FARMA FROM PT LOTUS FARMA INDONESIA NATCO PHARMA - COST OF ACQUISITION IS ABOUT 77 MILLION RUPEES Source text: ID:nNSEW2yQ3 Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees